• Home
  • About Us
    • Vision
    • People
      • Team
      • Senior Advisory
      • Medical Advisory
      • Consultants
    • Board
    • Funding
  • Technology
    • Platforms
    • Case Studies
    • Collaborations
    • Publications
    • White Paper
    • Pipeline
  • Media
    • Awards & Recognition
    • Newsroom
    • Blog
    • YouTube
  • Research Oncology Solutions (ROS)
    • Drug Discovery
    • Drug Repurposing
    • Clinical Translations
  • Gallery
  • Contact Us
  • Careers
  • Home
  • About Us
    • Vision
    • People
      • Team
      • Senior Advisory
      • Medical Advisory
      • Consultants
    • Board
    • Funding
      • Investors
      • Grants
  • Technology
    • Platforms
    • Case Studies
    • Collaborations
    • Publications
  • Research Oncology Solutions
    • Drug Discovery/ Drug Repurposing/Clinical Translations
  • Media
    • Awards & Recognitions
    • Newsroom
    • Blog
    • Youtube
  • Gallery
    • People
    • Labs
      • Main Lab
      • Tissue Culture
      • Animal House
      • Incubator
    • Instrumentation
  • Contact Us
  • Careers
  • Home
  • About Us
    • Vision
    • People
      • Team
      • Senior Advisory
      • Medical Advisory
      • Consultants
    • Board
    • Funding
  • Technology
    • Platforms
    • Case Studies
    • Collaborations
    • Publications
    • White Paper
    • Pipeline
  • Media
    • Awards & Recognition
    • Newsroom
    • Blog
    • YouTube
  • Research Oncology Solutions (ROS)
    • Drug Discovery
    • Drug Repurposing
    • Clinical Translations
  • Gallery
  • Contact Us
  • Careers

Author: Mestastop

Home » Archives for Mestastop
Uncategorized

Mestastop gets a 2.66 Cr grant from BIRAC for extending its proprietary drug discovery models into oral and breast cancer

Mestastop Solutions, a biotech company focused on stopping the spread of cancer, has been awarded a 2.66 Cr grant by BIRAC under the focused call of “establishment of preclinical models …

Uncategorized

Mestastop Solutions and Ectica Technologies participate in the Swiss Biotech Days 2024

This year, we are thrilled to welcome our partner, Mestastop Solutions Ltd., to Switzerland. Mestastop is an emerging Indian biotech firm with operational hubs in Bangalore, India, and New Jersey, USA.

Uncategorized

Mestastop Solutions and Vipragen Biosciences signs a Memorandum of Understanding.

Mestastop Solutions, a Bangalore-based cancer drug discovery start-up signed a memorandum

Uncategorized

Mestastop Solutions and St Johns Research Institute signed a Research Agreement.

Mestastop Solutions has entered into a Research Study Agreement with cancer researchers at

Uncategorized

Mestastop Solutions and Bangalore BioInnovation Centre collaborates to develop drug discovery models to combat cancer metastasis

Mestastop Solutions Pvt Ltd, a pioneering startup biotech working on complex cancer metast

Uncategorized

Mestastop Solutions signs collaboration agreement with IBAB, Bangalore

Mestastop Solutions have signed an Agreement with the Institute of Bioinformatics and Appl

Uncategorized

Mestastop announces agreement with H10AI

Mestastop Solutions®, based out of Marlton, New Jersey, has signed an agreement with H10A

Uncategorized

Mestastop Case Studies: how to change the cancer treatment paradigm

From 2003 to 2021, of all the 124 FDA-approved novel drugs for cancer, the net improvement

Uncategorized

Mestastop Solutions partners with Switzerland-based Ectica Technologies

Mestastop Solutions have partnered with Switzerland-based Ectica Technologies to pu

Posts navigation

Older posts

Recent Posts

  • Mestastop gets a 2.66 Cr grant from BIRAC for extending its proprietary drug discovery models into oral and breast cancer
  • Mestastop Solutions and Ectica Technologies participate in the Swiss Biotech Days 2024
  • Mestastop Solutions and Vipragen Biosciences signs a Memorandum of Understanding.
  • Mestastop Solutions and St Johns Research Institute signed a Research Agreement.
  • Mestastop Solutions and Bangalore BioInnovation Centre collaborates to develop drug discovery models to combat cancer metastasis

Recent Comments

No comments to show.

Archives

  • November 2024
  • April 2024
  • December 2023

Categories

  • Uncategorized
  • Home
  • About Us
  • Technology
  • Research Oncology Solutions
  • Media
  • Gallery
  • Contact Us
  • Careers
  • Privacy Policy
Linkedin Twitter Youtube